<p>Blue curve, patients whose physician used the MiCK assay. Red curve, patients whose physician did not use the MiCK assay.</p
<p>a. Recurrence-free survival curve for patients with pathologic T4 or T1-3 disease. b. Recurrence-...
<p>The survival curves for patients in different time durations (A) and with different tumor locatio...
BackgroundWe studied the relationship between time to ipsilateral breast tumor recurrence (IBTR) and...
<p>Time to recurrence in patients in the adjuvant <sup>125</sup>I brachytherapy vs. in the control g...
In the literature, small number of study has addressed time of recurrence in breast cancer. We analy...
<p>Overall recurrence rates among racially distinct staged breast cancer patients.</p
Objectives: Clinico-pathological factors affect the prognosis of breast cancer (BC) reflecting the h...
a. Time to ipsilateral breast tumour recurrence (IBTR). b. Ipsilateral breast tumour recurrence (IBT...
<p>Survival curves between treated and delayed/untreated patients of breast cancer at different stag...
<p>Time to cancer recurrence by duration of storage of transfused red blood cells.</p
Introduction - The risk of breast cancer recurrence has been linked to tumour size, grade, oestrogen...
Purpose. To determine the risk of late breast cancer recurrence (5 years after treatment) in a popul...
International audiencePurpose: The Time to First Metastatic Recurrence (TFMR) could be considered as...
To study the relationship between recurrence factors, recurrence sites, prognoses and disease free i...
Background: Treatment decisions in recurrent breast cancer are usually based on the estrogen (ER), p...
<p>a. Recurrence-free survival curve for patients with pathologic T4 or T1-3 disease. b. Recurrence-...
<p>The survival curves for patients in different time durations (A) and with different tumor locatio...
BackgroundWe studied the relationship between time to ipsilateral breast tumor recurrence (IBTR) and...
<p>Time to recurrence in patients in the adjuvant <sup>125</sup>I brachytherapy vs. in the control g...
In the literature, small number of study has addressed time of recurrence in breast cancer. We analy...
<p>Overall recurrence rates among racially distinct staged breast cancer patients.</p
Objectives: Clinico-pathological factors affect the prognosis of breast cancer (BC) reflecting the h...
a. Time to ipsilateral breast tumour recurrence (IBTR). b. Ipsilateral breast tumour recurrence (IBT...
<p>Survival curves between treated and delayed/untreated patients of breast cancer at different stag...
<p>Time to cancer recurrence by duration of storage of transfused red blood cells.</p
Introduction - The risk of breast cancer recurrence has been linked to tumour size, grade, oestrogen...
Purpose. To determine the risk of late breast cancer recurrence (5 years after treatment) in a popul...
International audiencePurpose: The Time to First Metastatic Recurrence (TFMR) could be considered as...
To study the relationship between recurrence factors, recurrence sites, prognoses and disease free i...
Background: Treatment decisions in recurrent breast cancer are usually based on the estrogen (ER), p...
<p>a. Recurrence-free survival curve for patients with pathologic T4 or T1-3 disease. b. Recurrence-...
<p>The survival curves for patients in different time durations (A) and with different tumor locatio...
BackgroundWe studied the relationship between time to ipsilateral breast tumor recurrence (IBTR) and...
DOI
Add to ORKG